glp 1 for chronic kidney disease GLP-1 Receptor Agonists and Diabetic Disease: A Call of Attention to Nephrologists Kidney Outcomes With Glucagon-Like Peptide-1
Description
The treatment gap is enormous
Henry Meds: Oral and Sublingual Options With No Membership Some patients cannot bring themselves to self-inject every week
Many rheumatologists are aware of the emerging data but have not been directly asked about it by patients
Does it promise dramatic weight loss
The NNTs for SGLT-2 inhibitors to reduce mortality are truly impressive, although 1 in 7 patients will get an additional genital infection in five years
